Dermata Therapeutics, Inc. (DRMA) Misses Q1 EPS by 207c

Dermata Therapeutics, Inc. (NASDAQ: DRMA) reported Q1 EPS of ($2.27), $2.07 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Dermata Therapeutics, Inc. (DRMA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• NVE Corporation names new CEO and expands board to seven members